Skip to content

A clinical trial to evaluate the effectiveness of Injectable platelet rich fibrin on the success of dental implants.

Comparative evaluation of peri implant soft tissue crestal bone height & bone density changes with or without the use of injectable platelet rich fibrin following implant placement in healed edentulous ridges A clinico radiographic split mouth study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100207
Enrollment
20
Registered
2026-01-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K084- Partial loss of teeth

Interventions

Intervention1: Injectable platelet rich fibrin (i-PRF): Implant placement in healed edentulous ridges by coating the implants with Injectable platelet rich fibrin (i-PRF). duration of intervention is

Sponsors

Dasmesh Institute of research and Dental Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients in the age group of 18 to 70 years. Systemically healthy individuals (American society of anesthesiologists I or II) Patients with bilateral edentulous sites indicated for implant placement. Patients with good oral hygiene. Patients with healthy, sufficiently sculpted and stable soft tissue architecture. Patients who will be able to attend the department at given recall visits.

Exclusion criteria

Exclusion criteria: Having acute infection at the site of implant placement. Systemic diseases such as diabetes or cardiac illness or conditions that would compromise the healing potential, osseous metabolic disorders etc. Smoking and alcohol abuse. Untreated periodontal disease. Usage of any medication that might interfere with the peri-implant healing process. Patients who are undergoing any kind of radiation therapy.

Design outcomes

Primary

MeasureTime frame
To evaluate the impact of injectable platelet-rich fibrin (i-PRF) on peri-implant soft tissue, crestal bone height and bone density changes in edentulous ridgesTimepoint: The outcome will be assessed at baseline, 3 months, and 6 months.

Secondary

MeasureTime frame
To evaluate & compare the clinical & radiographical parameters in the test & control groups at baseline & follow up periods.Timepoint: The outcome will be assessed at basline, 3 months & 6 months.

Countries

India

Contacts

Public ContactDr Ishita Vij

Dasmesh Institute of Research and Dental Sciences

nkhuller@yahoo.com8054443227

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026